类药物和子宫纤维瘤:一种新的治疗方法的潜力
D M C S Jayasundara1,2, I A Jayawardane1,2, T D K M Jayasingha1
1Department of Obstetrics and Gynecology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
概括
通过抑制生长和减少症状,他类药物在治疗子宫肌瘤方面表现有前途. 需要进一步的研究来确定这种常见的妇科病症的最佳使用.
科学领域:
- 妇科瘤学 妇科瘤学
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 子宫纤维瘤是常见的良性瘤,影响高达70%的女性,有效的长期医疗疗疗法有限.
- 目前的管理通常涉及手术,导致严重的发病率和经济负担.
- 目前正在研究其抑制纤维瘤生长和缓解症状的潜力.
研究的目的:
- 在子宫纤维瘤上探索他类药物的病理生理机制.
- 评估他类药物在治疗子宫纤维瘤方面的临床效果.
主要方法:
- 在主要数据库 (PubMed,Cochrane Library,Embase,ScienceDirect) 进行了系统的文献搜索,截至2025年1月.
- 包括的研究包括RCT,病例控制,横截面,队列,病例系列和英语实验研究.
- 数据综合涉及主题分析;研究质量使用NOS,RoB1和QUIN工具进行评估.
主要成果:
- 十三项研究 (八项实验,四项临床) 表明他类药物对瘤细胞具有不同的药理动力学效应.
- 类固醇降低了雌激素受体α水平,改变了细胞增殖途径,降低了ECM生产,诱导了亡,并改善了机械传导.
- 临床研究表明,他类药物显著降低了子宫纤维瘤的体积,并缓解了相关症状.
结论:
- 类他类药物对子宫纤维瘤表现出抗增殖和亲子亡作用,从而带来临床益处.
- 缺乏证据限制了关于比较疗效,最佳他类型,剂量和持续时间的结论.
- 建议进行精心策划的前性研究,以确定他类药物在子宫纤维瘤管理中的作用.
更多相关视频
06:22Ex Vivo Method for Assessing the Mouse Reproductive Tract Spontaneous Motility and a MATLAB-based Uterus Motion Tracking Algorithm for Data Analysis
Published on: September 1, 2019
9.5K
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
14.0K
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
01:26Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
443
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
443
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
01:31Transducer Mechanism: Nuclear Receptors
2.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.3K
01:15Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K